Cancer Communications
indexed by SCI
BMC

Important notice

 

 

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Cancer Communications is published by Wiley from 1 January 2020. The journal website is available at: https://onlinelibrary.wiley.com/journal/25233548

 

 

Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”


A novel Epstein‐Barr virus subtype associated with nasopharyngeal carcinoma found in South China
Lawrence S. Young
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/20/2020   doi:10.1002/cac2.12006
Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis
Haijing Liu, Bo Zhang, Zhifu Sun
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/18/2020   doi:10.1002/cac2.12005
The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study
Xue‐Song Sun, Sai‐Lan Liu, Yu‐Jing Liang, Qiu‐Yan Chen, Xiao‐Yun Li, Lin‐Quan Tang, Hai‐Qiang Mai
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/29/2020   doi:10.1002/cac2.12004
Identification of the surgical indication line for the Denonvilliers’ fascia and its anatomy in patients with rectal cancer
Jianglong Huang, Jing Liu, Jiafeng Fang, Zongheng Zeng, Bo Wei, Tufeng Chen, Hongbo Wei
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/18/2020   doi:10.1002/cac2.12003
Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram
Ailing Liu, Zhiheng Wang, Yachao Yang, Jingtao Wang, Xiaoyu Dai, Lijie Wang, Yuan Lu, Fuzhong Xue
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/3/2020   doi:10.1002/cac2.12002
Up‐regulation of indoleamine 2,3‐dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients
Qiang‐hua Zhou, Hui Han, Jia‐bin Lu, Ting‐yu Liu, Kang‐bo Huang, Chuang‐zhong Deng, Zai‐shang Li, Jie‐ping Chen, Kai Yao, Zi‐ke Qin, Zhuo‐wei Liu, Yong‐hong Li, Sheng‐jie Guo, Yun‐lin Ye, Fang‐jian Zhou, Ran‐yi Liu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/3/2020   doi:10.1002/cac2.12001
Global and regional burdens of oral cancer from 1990 to 2017: Results from the global burden of disease study
Zhen‐Hu Ren, Chuan‐Yu Hu, Hai‐Rong He, Yuan‐Jie Li, Jun Lyu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/18/2020   doi:10.1002/cac2.12009
Application of erector spinae plane block guided by ultrasound for postoperative analgesia in breast cancer surgery: A randomized controlled trial
Wensheng He, Zhenyu Wu, Lingjie Zu, Haijun Sun, Xiaochun Yang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/16/2020   doi:10.1002/cac2.12013
Haploidentical‐ versus identical‐sibling transplant for high‐risk pediatric AML: A multi‐center study
Feng-Mei Zheng, Xi Zhang, Chun-Fu Li, Yi-Fei Cheng, Li Gao, Yue-Lin He, Yu Wang, Xiao-Jun Huang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/16/2020   doi:10.1002/cac2.12014
Prognostic impact of gene copy number instability and tumor mutation burden in patients with resectable gastric cancer
Lisheng Cai, Linhai Li, Dandan Ren, Xue Song, Beibei Mao, Bo Han, Henghui Zhang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/6/2020   doi:10.1002/cac2.12007

more papers...






Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East,Guangzhou 510060, P.R.China